a16z Podcast: Apple and Google Won the Mobile OS War, But a New War Has Already Begun

The creation of each new biotechnology enables a tool, a therapy, or a diagnostic: a molecule, a protein, an app, a platform. And the process underneath isn't just complex in the science and engineering of it, but in the go to market. So who are the stakeholders in this process? In this podcast (which was originally recorded as a video), a16z bio fund general partners Jorge Conde and Vijay Pande give a quick hallway-conversation style overview on the stakeholders -- as well as what the process is from inception to approval to market; how do go-to-market models differ; and what should founders know at the beginning of each path.

16 Apr 20187min

Hypothesis, test, revise -- that's science. Engineering, however, doesn't quite go that way: You have parts you know and understand (like legos), and then you use those parts to design and build something (like bridges). But the key is that when science -- time-consuming, unpredictable, slow, expensive -- becomes more like engineering -- faster, more methodical/repeatable, cheaper -- you can do new things... or do them in better ways. This means engineering disciplines like mechanical engineering, electrical engineering, computer science, and materials science can carry over to biology. But the question is HOW does this happen, and how can entrepreneurs apply principles from one discipline to another? How does it affect a healthcare startup's go to market, and how might a shift like this affect the healthcare industry as a whole? Vijay Pande and Jorge Conde (general partners on our bio fund) reflect on all this and more in this hallway-style conversation episode of the a16z Podcast, which was originally recorded as a video.

16 Apr 201822min

with Lisa Hawke (@ldhawke) and Steven Sinofsky (@stevesi) Given concern around data breaches, the EU Parliament finally passed GDPR (General Data Protection Regulation) after four years of preparation and debate; it goes into enforcement on May 25, 2018. Though it originated in Europe, GDPR is a form of long-arm jurisdiction that affects many U.S. companies -- including most software startups, because data collection and user privacy touch so much of what they do. With EU regulators focusing most on transparency, GDPR affects everything from user interface design to engineering to legal contracts and more. That's why it's really about "privacy by design", argues former environmental scientist and lawyer Lisa Hawke, who spent most of her career in regulatory compliance in the oil industry and is now Vice President of Security and Compliance at a16z portfolio company Everlaw (she also serves as Vice Chair for Women in Security and Privacy). And it's also why, observes a16z board partner Steven Sinofsky, everyone -- from founders to product managers to engineers and others -- should think about privacy and data regulations (like GDPR, HIPAA, etc.) as a culture... not just as "compliance".  The two break down the basics all about GDPR in this episode of the a16z Podcast -- the why, the what, the how, the who -- including the easy things startups can immediately do, and on their own. In fact, GDPR may give startups an edge over bigger companies and open up opportunities, argue Hawke and Sinofsky; even with fewer resources, startups have more organizational flexibility, if they're willing to put in the work.  for links mentioned in this episode (and other resources), please go to: https://a16z.com/2018/04/12/gdpr-why-what-how-for-startups/

12 Apr 201835min

with Nicole Forsgren (@nicolefv), Jez Humble (@jezhumble) and Sonal Chokshi (@smc90) From the old claim that "IT doesn't matter" and question of whether tech truly drives organizational performance, we've been consumed with figuring out how to measure -- and predict -- the output and outcomes, the performance and productivity of software. It's not useful to talk about what happens in one isolated team or successful company; we need to be able to make it happen at any company -- of any size, industry vertical, or architecture/tech stack. But can we break the false dichotomy of performance vs. speed; is it possible to have it all?  This episode of the a16z Podcast boldly goes where no man has gone before -- trying to answer those elusive questions -- by drawing on one of the largest, large-scale studies of software and organizational performance out there, as presented in the new book, Accelerate: The Science of Lean Software and DevOps -- Building and Scaling High Performing Technology Organizations by Nicole Forsgren, Jez Humble, and Gene Kim. Forsgren (co-founder and CEO at DevOps Research and Assessment - DORA; PhD in Management Information Systems; formerly at IBM) and Humble (co-founder and CTO at DORA; formerly at 18F; and co-author of The DevOps Handbook, Lean Enterprise, and Continuous Delivery) share the latest findings about what drives performance in companies of all kinds. But what is DevOps, really? And beyond the definitions and history, where does DevOps fit into the broader history and landscape of other tech movements (such as lean manufacturing, agile development, lean startups, microservices)? Finally, what kinds of companies are truly receptive to change, beyond so-called organizational "maturity" scores? And for pete's sake, can we figure out how to measure software productivity already?? All this and more in this episode!

28 Mars 201844min

Few operators become VCs, and even fewer go back to leading companies... so how does these perspectives change how one leads? Obviously, it's a lot easier to think of a solution than execute on one... but then how does a leader empower one's team to do the right thing without micromanaging or without being frustrated when they're not getting what they wanted? (Hint: it has to do with providing context). In this episode of the a16z Podcast, Andy Rachleff (president and CEO of Wealthfront and alum of Benchmark) shares his thoughts on leadership, as well as his own journey as an entrepreneur in a particular vertical, in conversation with Bethany Coates, founder and CEO of BreakLine, which helps vets transition into tech. (The discussion took place during one of BreakLine's programs, co-designed and hosted at a16z). And since both are/were also teachers at Stanford's Graduate School of Business (where Rachleff still lectures, and where Coates served as Assistant Dean for their Global Innovation Programs) -- how does teaching make one a more authentic leader, given all the styles of leadership out there? All this and more in this episode.

26 Mars 201822min

Leadership is not just about management, but about passion, a bit of humor, and resilience. General partner Peter Levine and Dick Costolo (entrepreneur, former CEO of Twitter, and erstwhile comedian) share their thoughts on the topic in this episode of the a16z Podcast -- based on a conversation recorded as part of the BreakLine program (hosted at Andreessen Horowitz) preparing military veterans transitioning into tech careers. Among other things, Costolo shares what running Twitter was like pre-IPO and after, as well as what it’s like to suddenly find yourself thrust onto the world stage; the role of improv and imagery in leadership; and the difference between preventing mistakes from happening... and correcting them as quickly as you can when they do happen.

23 Mars 201823min

Focusing only on the technical, "crunchy, wonky stuff" behind policies or products sometimes misses the humanity at the center of why we're doing the thing in the first place. Because systems -- whether algorithms and artificial intelligence, or capitalism and other such "operating systems" -- need to work for people, not the other way around. Or so observes economist and author Arthur Brooks, president of the American Enterprise Institute (AEI) -- a public policy think tank focused on free enterprise (and where he recently announced he will be passing on the baton after a decade of leadership). So how does this philosophy of human dignity and human potential apply to automation and jobs, to education, to entrepreneurship? And not just in the "conventional" entrepreneurial sense of building companies and products -- but in changing one's life? The answer, argues Brooks in this quick, hallway-style episode of the a16z Podcast with Sonal Chokshi (recorded in one of our earlier Washington, D.C. roadshows) -- has to be rooted in the philosophy of human meaning. And that involves truly needing each other... so no one is left behind given technological progress and innovation. image credit: Maria Eklind/ Flickr

21 Mars 201824min

with Kristen Fortney (@kpfortney), Jeff Kaditz (@jeffkaditz), David Sinclair (@davidasinclair), and Hanne Tidnam (@omnivorousread) Even without a mythical fountain of youth, scientific advances have already dramatically increased how long humans live. But those advances to date have also largely been due to lower mortality rates, less infectious disease, and better nutrition. So when will modern medicine increase not just our healthspan, but our lifespan -- slowing down and possibly even reversing aging? What tools will it take? And what else, beyond the biology and technology involved, would change -- in our healthcare system and society as a whole? In this episode of the a16z Podcast -- recorded at a16z's November 2017 Summit -- Kristen Fortney, CEO and cofounder of BioAge Labs; Jeff Kaditz, CEO and cofounder of Q.Bio; David Sinclair, Co-Director of the Paul F. Glenn Center for the Biology of Aging at Harvard Medical School; and Michael Snyder, Professor and Department Chair of Genetics at Stanford University (as well as co-founder of and advisor to Q.Bio), in conversation with Hanne Tidnam, break down the science from the science fiction around the topics of longevity, health, and aging. image credit: Garry Knight/ Flickr ––– The views expressed here are those of the individual AH Capital Management, L.L.C. (“a16z”) personnel quoted and are not the views of a16z or its affiliates. Certain information contained in here has been obtained from third-party sources, including from portfolio companies of funds managed by a16z. While taken from sources believed to be reliable, a16z has not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation. This content is provided for informational purposes only, and should not be relied upon as legal, business, investment, or tax advice. You should consult your own advisers as to those matters. References to any securities or digital assets are for illustrative purposes only, and do not constitute an investment recommendation or offer to provide investment advisory services. Furthermore, this content is not directed at nor intended for use by any investors or prospective investors, and may not under any circumstances be relied upon when making a decision to invest in any fund managed by a16z. (An offering to invest in an a16z fund will be made only by the private placement memorandum, subscription agreement, and other relevant documentation of any such fund and should be read in their entirety.) Any investments or portfolio companies mentioned, referred to, or described are not representative of all investments in vehicles managed by a16z, and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. A list of investments made by funds managed by Andreessen Horowitz (excluding investments and certain publicly traded cryptocurrencies/ digital assets for which the issuer has not provided permission for a16z to disclose publicly) is available at https://a16z.com/investments/. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others. Please see https://a16z.com/disclosures for additional important information.

16 Mars 201817min